Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,616 GBX | -8.52% |
|
-7.53% | +10.95% |
01:30pm | GSK to Face Trials Over Zantac Cancer Allegations; Shares Tumble Pre-Bell | MT |
01:26pm | GSK : Sell rating from JP Morgan | ZD |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.96% | 91.66B | |
+40.73% | 739B | |
+31.16% | 598B | |
-6.30% | 353B | |
+15.15% | 318B | |
+4.05% | 285B | |
+15.02% | 240B | |
+9.49% | 210B | |
-5.15% | 206B | |
+6.17% | 164B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- Sector Update: Health Care Stocks Decline Premarket Friday